Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts.
Cell Transplant. 2016;25(4):677-86. doi: 10.3727/096368916X690863. Epub 2016 Feb 4.
Cell Transplant. 2016.
PMID: 26850319
Free PMC article.
Developing stem cell therapies for juvenile and adult-onset Huntington's disease.
Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA.
Fink KD, et al. Among authors: gruenloh w.
Regen Med. 2015;10(5):623-46. doi: 10.2217/rme.15.25.
Regen Med. 2015.
PMID: 26237705
Free PMC article.
Review.
Item in Clipboard
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.
Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA.
Pollock K, et al. Among authors: gruenloh w.
Mol Ther. 2016 May;24(5):965-77. doi: 10.1038/mt.2016.12. Epub 2016 Jan 14.
Mol Ther. 2016.
PMID: 26765769
Free PMC article.
Item in Clipboard
Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS.
Kambal A, et al. Among authors: gruenloh w.
Mol Ther. 2011 Mar;19(3):584-93. doi: 10.1038/mt.2010.269. Epub 2010 Nov 30.
Mol Ther. 2011.
PMID: 21119622
Free PMC article.
Item in Clipboard
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia.
Beegle JR, Magner NL, Kalomoiris S, Harding A, Zhou P, Nacey C, White JL, Pepper K, Gruenloh W, Annett G, Nolta JA, Fierro FA.
Beegle JR, et al. Among authors: gruenloh w.
Mol Ther Methods Clin Dev. 2016 Aug 24;3:16053. doi: 10.1038/mtm.2016.53. eCollection 2016.
Mol Ther Methods Clin Dev. 2016.
PMID: 27610394
Free PMC article.
Item in Clipboard
Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells.
Gruenloh W, Kambal A, Sondergaard C, McGee J, Nacey C, Kalomoiris S, Pepper K, Olson S, Fierro F, Nolta JA.
Gruenloh W, et al.
Tissue Eng Part A. 2011 Jun;17(11-12):1517-25. doi: 10.1089/ten.TEA.2010.0460. Epub 2011 Mar 4.
Tissue Eng Part A. 2011.
PMID: 21275830
Free PMC article.
Item in Clipboard
Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions.
Fierro FA, Magner N, Beegle J, Dahlenburg H, Logan White J, Zhou P, Pepper K, Fury B, Coleal-Bergum DP, Bauer G, Gruenloh W, Annett G, Pifer C, Nolta JA.
Fierro FA, et al. Among authors: gruenloh w.
Transfusion. 2019 Feb;59(S1):893-897. doi: 10.1111/trf.14914. Epub 2018 Nov 1.
Transfusion. 2019.
PMID: 30383901
Free PMC article.
Item in Clipboard
Cite
Cite